Fact Sheet

RxE HCV in Indiana

PhRMA December 14, 2015

Chronic hepatitis C (HCV) is a devastating viral disease that kills more Americans each year than HIV/AIDS. It is the leading cause of cirrhosis and liver cancer and is the most common reason for a liver transplant in the United States. Until recently, the only available treatment for HCV was a 48 week course of combination pegylated interferon/ribavirin which often came with debilitating, flu-like side effects and only cured about half of patients. The past couple years have seen a transformation in treatment with the introduction of a new generation of HCV medicines which provide cure rates upwards of 90% with minimal side effects and in as little as 8 weeks.

Download